Machine learning enhances early detection of glioma mutations

  • 📰 NewsMedical
  • ⏱ Reading Time:
  • 44 sec. here
  • 9 min. at publisher
  • 📊 Quality Score:
  • News: 45%
  • Publisher: 71%

Glioma News

Machine Learning,Brain,Gene

Machine learning (ML) methods can quickly and accurately diagnose mutations in gliomas – primary brain tumors.

May 20 2024Karl Landsteiner University of Health Sciences Machine learning methods can quickly and accurately diagnose mutations in gliomas – primary brain tumors.

Gliomas are the most common primary brain tumors. Despite the still poor prognosis, personalized therapies can already significantly improve treatment success. However, the use of such advanced therapies is based on individual tumor data, which is not readily available for gliomas due to their location in the brain. Imaging techniques such as magnetic resonance imaging can provide such data, but their analyses are complex, demanding and time-consuming.

In the current study, the team used ML methods to analyze and interpret these data in order to obtain a result more quickly and to be able to initiate appropriate treatment steps. But how accurate are the results obtained? To assess this, the study first used data from 182 patients at University Hospital St. Pölten, whose MRI data were collected according to standardized protocols.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 19. in EDUCATİON

Education Education Latest News, Education Education Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Machine learning tool identifies rare, undiagnosed immune disorders through patients' electronic health recordsResearchers say a machine learning tool can identify many patients with rare, undiagnosed diseases years earlier than current methods, potentially improving outcomes and reducing cost and morbidity. The findings, led by researchers at UCLA Health, are described in Science Translational Medicine.
Source: medical_xpress - 🏆 101. / 51 Read more »